Chrm1 encodes a receptor that is highly expressed in glutamatergic neurons [145] and in postsynaptic regions of the hippocampus [146], and is a potential target molecule for schizophrenia treatment [142]. This evidence concerns the gene CHRM1 and schizophrenia.